BDOUY vs GMED
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
BDOUY · BDO UNIBANK INC SPON ADR EA REPR 10 ORD PHP0.00$19.80 ▲ 1.02%
GMED · Globus Medical$71.05 ▼ 12.76%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- BDOUY -7.6%
- GMED -17.7%
Head to head
| Metric | BDOUY | GMED |
|---|---|---|
| Price | $19.80 | $71.05 |
| Change today | ▲ 1.02% | ▼ 12.76% |
| Market cap | $9.41B | $9.41B |
| Return, 3 months | -0.6% | -17.5% |
| Return, year to date | -11.5% | -18.6% |
| Return, 1 year | -7.0% | -15.3% |
| P/E (TTM) | 7.3 | 17.5 |
| P/B | 1.0 | 2.0 |
| P/E percentile vs own 5y | – | 7th |
| Dividend yield | 3.65% | – |
| Revenue growth (YoY, latest qtr) | – | +5.9% |
| Net profit growth (YoY) | – | -25.3% |
| Gross margin | – | 68.5% |
| Operating margin | – | 21.4% |
| Net margin | – | 17.0% |
| Return on equity | – | 11.8% |
| Analyst target vs. price | – | +41.1% |
| Analyst buy share | – | 75% |
| RSI (14) | 70 | 39 |
| 30-day volatility | 24.2% | 61.7% |
| Max drawdown, 1 year | -28.4% | -26.6% |
| Trend read | Leaning bullish | Strong downtrend |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- BDOUY is the largest of the group by market value.
- BDOUY has returned the most over the past year.
- BDOUY carries the lowest trailing P/E.
- BDOUY has been the calmest stock over the last 30 days.